Related Experiment Videos
Attention deficit disorder and methylphenidate: a multi-step analysis of dose-response effects on children's
K L Kelly1, M D Rapport, G J DuPaul
1Department of Psychiatry, State University of New York, Stony Brook 11794.
Insights
Methylphenidate (MPH) increases children's resting heart rate in a dose-dependent manner. These effects on heart rate (HR) depend on the initial HR and medication timing.
Area of Science:
- Pharmacology
- Pediatrics
- Neuroscience
Background:
- Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder in children.
- Methylphenidate (MPH) is a widely prescribed stimulant medication for ADHD.
- Understanding MPH's cardiovascular effects, specifically on heart rate (HR), is crucial for safe and effective treatment.
Purpose of the Study:
- To investigate the dose-response relationship between methylphenidate (MPH) and resting heart rate (HR) in children with ADHD.
- To determine the influence of pre-stimulus HR levels and time on MPH's effect on resting HR.
Main Methods:
- A double-blind, placebo-controlled, within-subject crossover design was employed.
- Forty-seven children diagnosed with ADHD participated.
- Children received five different doses of MPH in a counterbalanced sequence, with resting HR measured at each dose.
Main Results:
- A linear relationship was observed between higher MPH dosages and increased resting HR.
- The effect of MPH on HR was dependent on the child's baseline (pre-stimulus) HR.
- The time course of the medication also influenced the observed changes in resting HR.
Conclusions:
- Methylphenidate dosage is a significant determinant of resting heart rate changes in children with ADHD.
- Individual factors, including baseline heart rate and medication pharmacokinetics, modulate MPH's cardiovascular impact.
- These findings highlight the importance of individualized dosing and monitoring of cardiovascular parameters during MPH treatment.
Abstract:
The present study investigated the effects of methylphenidate (MPH) on the resting heart rate of 47 children with Attention Deficit Disorder/Hyperactivity. Children participated in a double-blind, placebo control, within subject (cross-over) design and received each of 5 doses of MPH in a counterbalanced sequence. A multi-step analysis was used to examine the dose-response relationship, contribution of pre-stimulus levels of HR (i.e. the initial value), and potential interaction between dosage and time on resting HR. Results indicated that higher dosages are linearly related to increasing levels of HR and that these effects are dependent upon both the initial HR value and the time course of the medication.